Health News Releases

October 15, 2023 11:11

Galderma Unveils Bold Ambition in Neuromodulation at Liquid Live Event

Galderma, the emerging pure-play dermatology category leader, today hosts the first edition of its Liquid Live event in Dubai as a chance to discuss with clinicians the future of innovation in the fie

October 13, 2023 15:15

AstraZeneca Awards Funding to Eight Innovative Research Projects From Early-Career Scientists Around the World in Second R&D Postdoctoral Challenge

AstraZeneca announced today eight winners of the 2023 R&D Postdoctoral Challenge (https://openinnovation.astrazeneca.com/rd-postdoctoral-challenge.html) and agreed to fund their postdoctoral positions

October 13, 2023 14:40

AI Medical Service Inc. Signs Joint Research Agreement with Leading Vietnamese Medical Institution

AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research agreement with Institute of Gastroenterology and

October 12, 2023 13:31

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based company, to develop, manufacture and commercialize SOFIE’s Gallium-68 and F

October 12, 2023 11:24

Galderma @ EADV 2023: Phase III Trials Demonstrate Nemolizumab’s Efficacy and Rapid Onset of Action in Atopic Dermatitis and Prurigo Nodularis

Galderma announced positive data from three pivotal phase III trials in atopic dermatitis and prurigo nodularis - ARCADIA 1 and 2 and OLYMPIA 1, respectively. The late-breaking data were presented tod

October 12, 2023 10:08

FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial

Care Access announced today the completion of a for-cause Food and Drug Administration (“FDA”) Good Clinical Practices (“GCP”) inspection related to Care Access’s activities on the Pfizer VALOR trial.

October 11, 2023 15:38

Evobrutinib, CNS-Penetrant BTKi, Has Shown Sustained Clinical Benefit Up to Five Years in People with RMS

Not intended for UK and U.S. based media Merck, a leading science and technology company, today announced new five-year data from the open-label extension (OLE) of the Phase II clinical trial, whic

October 11, 2023 08:58

Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.

Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, is pleased to announce that it has entered into an agreement to acquire the European rights to Duphaston® and

October 10, 2023 15:59

Merck Presents New MAVENCLAD® (Cladribine Tablets) Data Highlighting Sustained Reduction in NfLs and Benefit of Early Initiation

Not intended for UK and U.S. based media Merck, a leading science and technology company, today announced the presentation of new analyses from the MAVENCLAD® (cladribine tablets) MAGNIFY-MS study,

October 10, 2023 13:45

Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring

Masimo (https://www.masimo.com/) (NASDAQ: MASI) today announced the CE mark, under the European Union Medical Device Regulation, for the LiDCO® board-in-cable (BIC) module. The LiDCO BIC module is des

October 10, 2023 11:10

FDA Awards HistoSonics Clearance of its First-of-a-Kind Edison® Histotripsy System

HistoSonics®, (www.histosonics.com), the manufacturer of the Edison® System and novel histotripsy therapy platforms, announced today the marketing authorization of its “Breakthrough” platform via the

October 09, 2023 15:05

Phase III Studies to Investigate Survodutide for People Living with Obesity and Overweight, with and without Diabetes, Cardiovascular Disease and Chronic Kidney Disease

Boehringer Ingelheim and Zealand Pharma A/S (NASDAQ: ZEAL) announced the initiation of three Phase III trials investigating survodutide (also known as BI 456906) for people living with overweight or o

October 06, 2023 14:30

Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years

Takeda (https://www.takeda.com/) (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE)

October 06, 2023 11:04

Merck Launches New Collaboration with United Nations-Guided Global Initiative on Ageing to Support Carers

Merck, a leading science and technology company, today announced a new collaboration with the United Nations-Guided Global Initiative on Ageing (GIA) to provide a training course on critical skills fo

October 05, 2023 11:38

Woman Reunited With the Nurse Who Helped Save Her Life 30 Years Ago

A woman was reunited this week with a nurse who saved her life 30 years ago as she volunteers for the same charity that her rescuers were from. In 1993, Catherine Conteh was enduring an agonizing f

October 04, 2023 15:05

EADV 2023: Galderma to Present New Data Showcasing Its Continued Leadership in Dermatology

Galderma, the emerging pure-play dermatology category leader, announced today it will be showcasing updates from across its broad and innovative dermatology portfolio at the 32nd European Academy of D

October 04, 2023 13:35

RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer

RoslinCT, a leading contract development and manufacturing organization (CDMO) for Advanced Cell and Gene Therapies, is pleased to announce the appointment of Dean J. Morris as the Chief Operations Of

October 04, 2023 11:10

Takeda Provides Update on EXKIVITY® (mobocertinib)

Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that, following discussions with the U.S. Food and Drug Administration (FDA), it will be working with the FDA to

October 03, 2023 11:57

Galderma announces progress with RelabotulinumtoxinA regulatory submissions

Galderma, the emerging pure-play dermatology category leader, announced today updates related to the regulatory progress of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA (Q

October 03, 2023 11:27

Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss

Boehringer Ingelheim and ZEISS Medical Technology announce today a long-term strategic collaboration to develop predictive analytics to enable early detection of eye diseases and prevent vision loss f

October 01, 2023 10:45

Organon Recognized on Fortune’s 2023 Change the World List for Leadership in Expanding Access to Contraceptive Choice

Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, has been named to Fortune’s 2023 Change the World list for its leadership in helping women and girls around the world t

September 27, 2023 10:40

Medisca Takes Steps to Protect its Innovative Technologies

Through decades of strategic research and development (“R&D”) investment, the Medisca name has become synonymous with innovative, customer-focused technologies. In compounding, for example, Medisca co

September 26, 2023 10:25

Korean Unicorn APR Files for Preliminary IPO Review on KRX

APR (https://www.apr-in.com/), a beauty-tech company APR (CEO Byung-hoon Kim) announced today that it filed for a preliminary review on the Korea Exchange (KRX) on September 22. Shinhan Securities

September 26, 2023 10:15

Aster Guardians Global Nursing Award 2024 is Now Open for Entry Worldwide, One Nurse Will Win the US $250,000 Award

In its continued efforts to recognize the contribution of nurses to humanity and the healthcare community, Aster DM Healthcare has announced the third edition of the Aster Guardians Global Nursing Awa

September 24, 2023 11:15

Kenvue to Announce Third Quarter 2023 Results on October 26, 2023

Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, will announce its financial results for the third quarter ending October 1, 2023, before market o

News by Region

News by Industry